Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00583479 · ClinicalTrials.gov registry record · Phase 4
Prospective Study of Celiac Block Injection: 1 vs. 2
A Phase 4 study of Pancreatic Cancer and Chronic Pancreatitis, sponsored by Indiana University.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT00583479: Completed Phase 4 study of Pancreatic Cancer and Chronic Pancreatitis, sponsored by Indiana University.
NCT00583479 is a Phase 4 study of Pancreatic Cancer and Chronic Pancreatitis that has completed, run by Indiana University. The registered enrollment target is 100 participants, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00583479, a Phase 4 study of Pancreatic Cancer and Chronic Pancreatitis, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this prospective randomized study is to compare the clinical effectiveness of EUS-guided CB performed with a single injection versus two injections of medication into the celiac ganglion region.
Conditions Studied
Interventions
- OTHER one injection into the celiac ganglion
- OTHER two injections into the celiac ganglion
Study Locations (1)
Indiana
- Clarian Health: Indiana University Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2002-06 |
| Est. Completion | 2008-07 |
| Phase | Phase 4 |
What the finished NCT00583479 record still lists
NCT00583479 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (75% lower).
The record links to 2 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 2 interventions - of which one injection into the celiac ganglion is the first listed.
NCT00583479 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT00583479 about?
NCT00583479 is a clinical study titled "Prospective Study of Celiac Block Injection: 1 vs. 2". The purpose of this prospective randomized study is to compare the clinical effectiveness of EUS-guided CB performed with a single injection versus two injections of medication into the celiac ganglion region.
What is the current status of trial NCT00583479?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2002-06. Estimated completion is 2008-07.
What conditions does trial NCT00583479 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Chronic Pancreatitis.
What interventions are being tested in trial NCT00583479?
The interventions under investigation include: one injection into the celiac ganglion (OTHER), two injections into the celiac ganglion (OTHER).
Who is sponsoring clinical trial NCT00583479?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00583479 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00583479's enrollment target sits among peer trials
100 106th of 278 higher than 170 of 278 other Pancreatic Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreatic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study
COMPLETED · Phase 4
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
RECRUITING · Phase 1
-
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia